美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · BVS近 30 天 1 則 · 第 1 / 1 頁
- Are Medical Stocks Lagging Bioventus (BVS) This Year?
- Bioventus (BVS) Stock Still Looks Like A Bargain On Earnings
- Bioventus Inc (BVS) (Q2 2026) Earnings Call Highlights: Strategic Review and Strong HA Growth ...
- Bioventus (BVS) Q2 Earnings Meet Estimates
- Bioventus Reports Second Quarter Financial Results
- Is Bioventus (BVS) Stock Outpacing Its Medical Peers This Year?
- Does Bioventus (BVS) Have the Potential to Rally 28.92% as Wall Street Analysts Expect?
- Should Value Investors Buy Bioventus (BVS) Stock?
- Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year?
- Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice
- Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?
- Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。